No time frame rather just a time line has been implemented in my opinion. FDA approvals etc are not within a time frame but are part of a time line and not controlled by Archer. I would be worried if companies like VTT showed no interest but interest is there. Thumbs up to that!
If it goes well with VTT early 2025 could see back end of development phase of the biochip technology being put into implementation. :- Archer expects to receive the gFET sensor chips back from VTT in the first half of 2025 and will use the sensor chips to develop multi-analyte biosensors.
All companies that have no revenue are speccie stocks mate. I'm down 70% here up 390% on DUG.
No time frame rather just a time line has been implemented in my...
Add AXE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.005(1.92%) |
Mkt cap ! $67.53M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 27.0¢ | 26.0¢ | $29.40K | 111.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5962 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 40677 | 2 |
View Market Depth
| Last trade - 15.25pm 05/11/2024 (20 minute delay) ? |
| AXE (ASX) Chart |